Hepatic and renal effects of peroxisome proliferators: biological implications.
D000502:Allylisopropylacetamide / Q000494:pharmacology; D000818:Animals; D002332:Carnitine O-Acetyltransferase / Q000378:metabolism; D002374:Catalase / Q000096:biosynthesis; D002994:Clofibrate / Q000494:pharmacology; D007668:Kidney / Q000378:metabolism / Q000648:ultrastructure*; D050356:Lipid Metabolism; D008062:Lipofuscin / Q000378:metabolism; D008099:Liver / Q000378:metabolism / Q000648:ultrastructure*; D051379:Mice; D008830:Microbodies / Q000187:drug effects / Q000378:metabolism / Q000648:ultrastructure*; D008939:Mitotane / Q000494:pharmacology; D009940:Organoids / Q000648:ultrastructure*; D010455:Peptides / Q000302:isolation & purification*; D010634:Phenobarbital / Q000494:pharmacology; D051381:Rats
D008062:Lipofuscin; D010455:Peptides; C033176:polypeptide PPA-80; D000502:Allylisopropylacetamide; D008939:Mitotane; D002374:Catalase; D002332:Carnitine O-Acetyltransferase; D002994:Clofibrate; D010634:Phenobarbital